Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

View source ↗

Summary

A real-world study is evaluating Mecapegfilgrastim injections to prevent neutropenia in patients undergoing tumor treatment; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mecapegfilgrastim

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Neutropenia | Status: RECRUITING